Bill
SF 202
A state board must create rules to make prescription labels, bag tags, and guides accessible for blind or print-disabled users, and report costs and funding options by Jan 1, 2026.
Note on source materials
- The bill title supplied is “Minnesota Partition Act Establishment,” and the bill classification lists subjects such as eminent domain and land legal proceedings. However, the only substantive text excerpt provided concerns accessibility of prescription drug labels and a reporting requirement. The legislative actions show the measure was enacted (Chapter 2) and approved by the Governor on March 28, 2025. Because of this internal inconsistency, this summary focuses on the concrete provisions and timeline present in the supplied text and legislative history. Consult the official enrolled bill or chaptered law for the final authoritative language.
Purpose and intent
- The bill directs a named board (unspecified in the excerpt) to implement rules and report on steps to improve access to prescription information for persons who are blind, visually impaired, or have a print disability. The overall intent is to improve access to prescription drug labels, bag tags, and medical guides and to identify funding mechanisms (including enhanced dispensing fees) to cover those accessibility costs.
Key provisions (from provided excerpt)
- Rule implementation: The board is required to implement rules to improve accessibility of prescription drug materials (labels, bag tags, medical guides).
- Reporting requirement: The board must submit a report to the Governor and the Minnesota Legislature by January 1, 2026. The report must include:
- Progress made implementing the rules;
- Recommendations for additional measures to improve accessibility; and
- Projected costs of implementing “enhanced dispensing fees” intended to defray the costs of providing accessible prescription drug labels, bag tags, and medical guides to eligible persons.
- Cost recovery: The text contemplates use of an enhanced dispensing fee as a funding mechanism, and requires projected-cost information to support any such fee proposal.
Who would be affected
- Directly affected: persons who are blind, have a visual impairment, or have a print disability who rely on accessible prescription materials.
- Operationally affected: pharmacies, dispensing providers, and the regulatory board charged with rulemaking and reporting. Employers or payers could be indirectly affected if dispensing fees change.
- Policy stakeholders: disability advocacy groups, pharmacist associations, insurers, and state budget/administrative offices evaluating fee structures.
Procedural and timeline highlights
- Introduced: February 4, 2025.
- Committee activity and readings: Multiple committee referrals and readings throughout February–March 2025.
- Passed both chambers: March 20, 2025 (House third reading recorded March 20).
- Governor approval and chaptered: Approved by Governor and filed with Secretary of State on March 28, 2025 (Chapter 2, 03/28/25).
- Required report due: January 1, 2026.
Related and sponsor information
- Primary sponsor: Senator Bisignano.
- Companion bill: HF 359.
- Committees referenced in history include Health and Human Services; Judiciary Finance and Civil Law; Judiciary and Public Safety.
Note and recommendation
- Because the supplied bill title and subject area conflict with the excerpted text, readers should review the official chaptered law (Chapter 2, Laws of Minnesota 2025) or the enrolled bill text to confirm the bill’s full scope, the identity of the board named, and any provisions not present in the excerpt.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
